These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23448467)

  • 1. Targeting histone acetylation for neuroprotection.
    Contestabile A
    Curr Pharm Des; 2013; 19(28):5017-8. PubMed ID: 23448467
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.
    Valor LM; Viosca J; Lopez-Atalaya JP; Barco A
    Curr Pharm Des; 2013; 19(28):5051-64. PubMed ID: 23448461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone post-translational modifications to target memory-related diseases.
    Monti B
    Curr Pharm Des; 2013; 19(28):5065-75. PubMed ID: 23448462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromatin acetylation status in the manifestation of neurodegenerative diseases: HDAC inhibitors as therapeutic tools.
    Anne-Laurence B; Caroline R; Irina P; Jean-Philippe L
    Subcell Biochem; 2007; 41():263-93. PubMed ID: 17484132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?
    Fischer A
    Neuropharmacology; 2014 May; 80():95-102. PubMed ID: 24486385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone acetylation in neurodevelopment.
    Contestabile A; Sintoni S
    Curr Pharm Des; 2013; 19(28):5043-50. PubMed ID: 23448460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Histone Acetylation by Autophagy in Parkinson Disease.
    Park G; Tan J; Garcia G; Kang Y; Salvesen G; Zhang Z
    J Biol Chem; 2016 Feb; 291(7):3531-40. PubMed ID: 26699403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents.
    Langley B; Gensert JM; Beal MF; Ratan RR
    Curr Drug Targets CNS Neurol Disord; 2005 Feb; 4(1):41-50. PubMed ID: 15723612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond.
    Konstantinopoulos PA; Karamouzis MV; Papavassiliou AG
    Expert Opin Investig Drugs; 2007 May; 16(5):569-71. PubMed ID: 17461732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis.
    Saha RN; Pahan K
    Cell Death Differ; 2006 Apr; 13(4):539-50. PubMed ID: 16167067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery.
    Fessler EB; Chibane FL; Wang Z; Chuang DM
    Curr Pharm Des; 2013; 19(28):5105-20. PubMed ID: 23448466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone acetylation modulation by small molecules: a chemical approach.
    Rekowski Mv; Giannis A
    Biochim Biophys Acta; 2010; 1799(10-12):760-7. PubMed ID: 20493978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone acetylation as a potential therapeutic target in motor neuron degenerative diseases.
    Garbes L; Riessland M; Wirth B
    Curr Pharm Des; 2013; 19(28):5093-104. PubMed ID: 23448465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
    Steffan JS; Bodai L; Pallos J; Poelman M; McCampbell A; Apostol BL; Kazantsev A; Schmidt E; Zhu YZ; Greenwald M; Kurokawa R; Housman DE; Jackson GR; Marsh JL; Thompson LM
    Nature; 2001 Oct; 413(6857):739-43. PubMed ID: 11607033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone post-translational modifications in Huntington's and Parkinson's diseases.
    Peña-Altamira LE; Polazzi E; Monti B
    Curr Pharm Des; 2013; 19(28):5085-92. PubMed ID: 23448464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylation.
    Hardcastle A; Tomlin P; Norris C; Richards J; Cordwell M; Boxall K; Rowlands M; Jones K; Collins I; McDonald E; Workman P; Aherne W
    Mol Cancer Ther; 2007 Mar; 6(3):1112-22. PubMed ID: 17363504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histone acetylation, gene regulation and depression].
    Vialou V
    Med Sci (Paris); 2010 May; 26(5):465-7. PubMed ID: 20510142
    [No Abstract]   [Full Text] [Related]  

  • 18. Manipulation of the host protein acetylation network by human immunodeficiency virus type 1.
    Jeng MY; Ali I; Ott M
    Crit Rev Biochem Mol Biol; 2015; 50(4):314-25. PubMed ID: 26329395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?
    Ziemka-Nalecz M; Jaworska J; Sypecka J; Zalewska T
    J Neuropathol Exp Neurol; 2018 Oct; 77(10):855-870. PubMed ID: 30165682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human neuronal cells: epigenetic aspects.
    Kukucka J; Wyllie T; Read J; Mahoney L; Suphioglu C
    Biomol Concepts; 2013 Aug; 4(4):319-33. PubMed ID: 25436583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.